Stimulants Methylphenidate (Ritalin, Concerta, Daytrana) Dexmethylphenidate (Focalin) Amphetamine/dextroampheta mine (Adderall) Dextroamphetamine (Dexedrine)

Slides:



Advertisements
Similar presentations
ADD Update Kristi Maroni, MD Lance Feldman, MD, MBA, BSN.
Advertisements

Nora D. Volkow, M.D. Director National Institute on Drug Abuse National Institutes of Health Overlapping Neuronal Circuits In.
Attention Deficit Hyperactivity Disorder
Attention-Deficit/ Hyper Activity Disorder ( ADHD) By: Bianca Jimenez Period:5.
ADHD, Executive Functions and PKU Kevin M. Antshel, Ph.D. Associate Professor of Psychiatry / Licensed Psychologist State University of New York – Upstate.
AD/HD General Medical Information Mary Margaret Dagen, M.D. Mary Margaret Dagen, M.D. Westshore Family Medicine Westshore Family Medicine April 24, 2013.
Pharmacological Treatment of Child & Adolescent ADHD.
For Cost Effective Pharmacologic Treatment NC Academic Consortium 1 John M. Diamond, M.D. Division of Child and Adolescent Psychiatry Brody School of Medicine.
Attention-Deficit Hyperactivity Disorder in Adults and Children Conceptualization, Diagnosis and Treatment An Integrated Approach By Ghada Hamdan-Allen,
Overview of Mental Health Medications for Children and Adolescents Module 5 ADHD and Disruptive Behavior Disorders 1.
Attention Deficit Hyperactivity Disorder. Kevin Leehey M.D E. Fort Lowell Rd. Suite 150 Tucson, AZ fax
Improving behavioral health through the power of clinical expertise and advanced technology New York Business Group on Health Maximizing Behavioral Health.
Psychopharmacology and Developmental Disorders Woodfords Family ServiceKatherine Ray, MD Psychiatry ServicesDouglas Patrick, LCSW PO Box 1768 Portland,
Chemically Modifying Behaviors Copyright 2010:PEER.tamu.edu.
Bringing the Full Power of Science to Bear on Bringing the Full Power of Science to Bear on NIDA NATIONAL INSTITUTE ON DRUG ABUSE Drug Abuse & Addiction.
Ghs.org ADHD and the Concussed Athlete S. David Blake, MD Fellow Department of Developmental-Behavioral Pediatrics Children’s Hospital Greenville Hospital.
Drugs for the treatment of Attention-Deficit Hyperactivity Disorder
By: Heather Willis.  Inattention -- A child with ADHD:  Is easily distracted  Does not follow directions or finish tasks  Does not appear to be listening.
Attention Deficit Disorder By Jake K.  Attention deficit disorder also referred to as ADD, is a biological brain based condition that is characterized.
Anxiety and Depression. PREVALENCE ANXIETYDEPRESSION 16+ Million Adults in the U.S. have anxiety disorders. Generalized anxiety disorder affects 3-8%
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 36 Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder.
Effect of Brain Stimulation on Attention Itai Admi Guy Rosenmann Yair Levi.
Drug Safety and Risk Management Advisory Committee February 9, 2006 Overview of ADHD and its Pharmacotherapy Andrew D. Mosholder, M.D., M.P.H. FDA Division.
Director, National Institute on Drug Abuse National Institute Alcohol
Discuss validity and reliability of diagnosis
And Alzheimer’s Disease
ADHD and Psychopharmacology By Monica Robles M.D.
An Educational Perspective Based on Information Contained In The Indiana Prevention Resource Center Factline on Ritalin ®.
LOVE IN THE TIME OF CRYSTAL METHAMPHETAMINE World Psychiatric Association Athens, Greece March 15, 2005 Petros Levounis, M.D. Director, The Addiction.
Cocaine, Amphetamines, and Other Behavioral Stimulants Chapter 7 Tamyra Frazier & Sarah Massamore.
Psychoactive Medications and ASD. Considering Pharmacologic Intervention Why would we consider using psychopharmacologic agents to treat problems in a.
The Role of the Primary Care Provider in the Diagnosis and Treatment of Attention Deficit / Hyperactivity Disorder Carla M. Thacker PAS 646 March 22, 2007.
Early Onset of Schizophrenia Spectrum Disorder l Premorbid history l Attention problems l Social impairment l Language abnormalities.
RESPONSE TO ANTIDEPRESSANT MEDICATION, COGNITIVE BEHAVIOR THERAPY AND PLACEBO IN CHRONIC TENSION-TYPE HEADACHE VARIES WITH PSYCHIATRIC COMORBIDITY & HEADACHE.
Soaud Dupree EEC 4731 Milestone 1.  ADHD- “a syndrome of attention and behavior disturbances that may improve when stimulant-type drugs are administered.”
ADHD for School Nurses Jackie Tomberlin, MS, RN.
It Was first discovered by a British Doctor and was called “Defect of Moral Control” Symptoms now associated with ADHD were documented and given a diagnosis.
ADD/ADHD By: Ashley Marriott. Attention Deficit Disorder and Attention Deficit Hyperactivity Disorder are syndromes, usually diagnosed in childhood, characterized.
Pain Management Laura Bergs FNP. Definition of Chronic Pain Anyone with pain greater than 3 months Anyone with pain greater than 3 months Pain An unpleasant.
Drugs used in treatment of addiction
LEADING RESEARCH… MEASURES THAT COUNT Challenges of Studying Cardiovascular Outcomes in ADHD Elizabeth B. Andrews, MPH, PhD, VP, Pharmacoepidemiology and.
ADHD MEDICATIONS Myths and Facts ADHD Awareness Day, Oct 2011 by Theresa Cerulli, M.D. Neuropsychiatrist.
Attention-Deficit / Hyperactivity Disorder (ADHD) Trouble du déficit de l’attention/hyperactivité (TDAH) Claude Jolicoeur. m.d.
The Neurobiology of Free Will In National Institute on Drug Abuse
MEDICATION TREATMENT OF ADHD CSNO Conference February 9, 2013 Thomas S. Jensen, MD Sorrento Valley Road, Suite 390 San Diego, CA /
Attention Deficit Hyperactivity Disorder (ADHD). Definition Attention deficit hyperactivity disorder; a disorder characterized by a persistent pattern.
Chapter – 27 ATTENTION DEFICIT HYPERACTIVITY DISORDER.
ADHD 9 th dec Dr. Sami Adil. ADHD is a neuropsychiatric condition starting since childhood characterized by diminished sustained attention, and.
Treating Mental Disorders. Community Resources  50 million Americans experience mental disorders  Majority do not seek help  What could keep a person.
Developmental Considerations Most Common Adjustment Problems –Attachment problems or developmental delays in.
What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.
NATIONAL INSTITUTE ON DRUG ABUSE NIDA NIAAA National Institute Alcohol Abuse and Alcoholism Nora D. Volkow, M.D. Director, National Institute on Drug Abuse.
 ADHD PSYCHO- EDUCATIONAL & SUPPORT GROUP Jennah Beilgard & Kathy Stavropoulos.
Bipolar Disorder. What is it? Definition: “previously known as manic depression - is a condition that affects your moods, which can swing from one extreme.
P EDIATRIC ADHD E VALUATIONS AT FMC. ADHD C RITERIA DSM 5 Children must have ≥ 6 sxs from either or both the inattentive and the hyperactivity and impulsivity.
Pharmacologic Considerations in the Treatment of ADHD in Adults Presented by: Ann M. Wheeler, PharmD, BCPP Date: 3/31/2016.
Strattera Available Generic Cheap Strattera Online atomoxetine vs desipramine strattera side effects throat purchase strattera no prescription does strattera.
The Science of Addiction. Homelessness Crime Violence Homelessness Crime Violence Neurotoxicity AIDS, Cancer Mental illness Neurotoxicity AIDS, Cancer.
Title Slide Subtitle.
Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder.
Students with Attention Deficit- Hyperactivity Disorder
Carmen Hernandez February 4, 2017
ADHD.
Should children be prescribed psychostimulants at such a young age?
Attention-Deficit/ Hyperactivity Disorder
ADHD Attention deficit hyperactivity disorder
Substance-Related and Addictive Disorders
Dion Gallant, MD Presbyterian Medical Group
The Challenges of Bipolar Disorders
A ttention D eficit H yperactivity D isorder By: Bo Zhong.
Presentation transcript:

Stimulants Methylphenidate (Ritalin, Concerta, Daytrana) Dexmethylphenidate (Focalin) Amphetamine/dextroampheta mine (Adderall) Dextroamphetamine (Dexedrine) Lisdexamfetamine (Vyvanse) Modafinil,amodafinil (Provigil/Nuvigil) Antidyskinetic/Antiviral Amantadine (Symmetrel) Alpha agonists Clonidine, Guanfacine (Kapvay, Intuniv) Non-stimulants Atomoxetine (Strattera) Buproprion (Welbutrin) Tricyclics Imipramine, Desipramine, Nortriptylene SSRIs/SNRIs Fluoxetine (Prozac) Venlafaxine (Effexor) Mood Stabilizers/Antipsychotics

Amphetamine is a stimulant that is primarily used to treat narcolepsy and attention-deficit hyperactivity disorder. It is also used recreationally as a club drug and as a performance enhancer. Prescription amphetamines are subject to diversion and are one of the most frequently- abused drugs in high schools and colleges. A Schedule II drug is classified as one that has a high potential for abuse, has a currently-accepted medical use under severe restrictions, and has a high possibility of severe psychological and physiological dependence.

hr Time After Nicotine % of Basal Release Accumbens Caudate NICOTINE Di Chiara and Imperato, PNAS, 1988

CA PUT Striatum VTA/SN CG PreF OFC nucleus accumbens

(0-10)

(MP - Placebo)

Pl/PL PL/MP MP/MP MP/PL Feel Drug Pl/PL PL/MP MP/MP MP/PL High Pl/PL PL/MP MP/MP MP/PL Like Drug Pl/PL PL/MP MP/MP MP/PL Restlessness Source: Volkow, ND et al., Journal of Neuroscience, 23, pp , December 2003.

Two interviewers had to agree with diagnosis (MD, PhD, PNP) Hx of stimulant abuse not exclusionary unless DOC Initial poor outcomes on Adderall led to switch to “safer” drugs (e.g. Concerta, Vyvanse) One psychiatrist did all med. adjustments Inclusion No discussion on unit 1 year enrollment in treatment Leaving treatment meant no follow- up from providers 1+ prior CD treatments All had CBT manually/workbook driven and special groups with psychiatrist and psychiatric NP Behavioral problems resulted in one verbal warning, then behavioral contract, then discharge N=43 Ages 18-55

100% (43/43) participants were relapsed and/or lost to follow-up. 31% of controls (12/39) relapsed and/or were lost to follow-up Only 25% of the stimulant group had abused stimulants in the past There were many more behavioral discharges in the stimulant vs. control groups though the disease severity was equal. (Some of the control group participants were given Welbutrin or Clonidine. Strattera was not available at the time of the study.) Stimulants do not work in the 1 st year of treatment.

ADD is very difficult to diagnose There is no distinct profile on testing, most of what is used in adults is self-report, and even sophisticated testing can be “fooled” Expectancy effects on self-report of symptoms and treatment (with stimulants) are large Because a person likes having more energy and can “get more done” on stimulants, it does not mean they have ADD. Most experienced practitioners, if they are brutally honest, will probably admit that they are almost never sure about the diagnosis. The best predictor of the likely diagnosis of ADD is the patient deciding they have it. The greatest disability that can be directly linked to the diagnosis is academic difficulty. ADD symptoms and personality traits are difficult to differentiate. People want a quick fix.

Living in the solution One day at a time, easy does it, first things first, keep it simple Acceptance Utilize tools such as smart phones Delegate View the energy and creativity as wonderful gifts Consider safe medications, but don’t expect to be “normal” (False expectation of stimulants as cure.)